Related Experiment Videos
Cholestasis after hematopoietic cell transplantation
S I Strasser1, H M Shulman, G B McDonald
1Gastroenterology/Hepatology Section, Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, Washington, USA.
Clinics in Liver Disease
|April 9, 2001
Summary
Cholestasis and jaundice frequently occur after hematopoietic cell transplantation due to various factors. Identifying these causes is crucial for effective patient management and treatment strategies.
Area of Science:
- Hematology
- Transplantation Medicine
- Gastroenterology
Background:
- Cholestasis and jaundice are recognized complications following hematopoietic cell transplantation (HCT).
- Multiple underlying etiologies can contribute to the development of cholestasis in HCT recipients.
- Understanding these causes is vital for timely diagnosis and intervention.
Purpose of the Study:
- To review and summarize the common causes of cholestasis and jaundice post-hematopoietic cell transplantation.
- To provide a comprehensive overview of the differential diagnoses in this clinical setting.
Main Methods:
- Literature review of studies and clinical guidelines related to post-HCT cholestasis.
- Synthesis of information on various contributing factors and their mechanisms.
Main Results:
- Identified common causes including sepsis, hemolysis, cyclosporine, drug toxicity, and parenteral nutrition.
- Highlighted graft-versus-host disease, viral infections, and extrahepatic obstruction as significant contributors.
- Emphasized the multifactorial nature of cholestasis in HCT patients.
Conclusions:
- Cholestasis after HCT is a complex condition with a broad differential diagnosis.
- Systematic evaluation is necessary to pinpoint the specific cause(s) in each patient.
- Effective management hinges on accurate identification and treatment of the underlying etiology.